Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Androgen receptor splice variant 7 (AR-V7) detection in circulating tumor cells (CTCs) is associated with a low probability of response and short progression-free (PFS) and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide or...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JCO Precis Oncol
Main Authors: Armstrong, Andrew J., Luo, Jun, Nanus, David M., Giannakakou, Paraskevi, Szmulewitz, Russell Z., Danila, Daniel C., Healy, Patrick, Anand, Monika, Berry, William R., Zhang, Tian, Harrison, Michael R., Lu, Changxue, Chen, Yan, Galletti, Giuseppe, Schonhoft, Joseph D., Scher, Howard I., Wenstrup, Richard, Tagawa, Scott T., Antonarakis, Emmanuel S., George, Daniel J., Halabi, Susan
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2020
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7608579/
https://ncbi.nlm.nih.gov/pubmed/33154984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00200
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares